Podcast series
In February 2024 we launched the exciting new BGCS podcast. The team, led by Dr Neil Ryan from Edinburgh, interviews experts from around the world on topics of interest as well as new research and pertinent quality improvement and audit projects.
This is an excellent educational and CPD resource for all.
The podcasts are great company for your commute to work or your dog walk, and really do make CPD interesting and easy!
In this inaugural episode Prof Christina Fotopoulou and Prof Sean Kehoe discuss the evidence surrounding surgery in ovarian cancer.
Download podcast
The SHAPE trial – a discussion with Dr Plante. Dr Plante is Principal Investigator on the SHAPE study.
Download podcast
Professor Ranjit Manchanda discusses NICE guidance on identifying familial and genetic risk for ovarian cancer and delayed risk reducing surgery.
Download podcastWelcome to the another BGCS podcast, where we explore the latest advances in gynecologic cancer care. Here is a brief introduction for the podcast on HIPEC in ovarian cancer, featuring Prof. WJ van Driel and Ms. Claire Thompson.
Welcome to this special episode of the BGCS podcast. Today, we’ll be discussing a critical advancement in the treatment of ovarian cancer—HIPEC (Hyperthermic Intraperitoneal Chemotherapy). Joining us are two esteemed experts in this field: Prof. WJ van Driel, a renowned researcher and surgical oncologist from the Netherlands Cancer Institute, whose groundbreaking work on HIPEC has shaped clinical practice worldwide, and Ms. Claire Thompson, a leading Consultant Gynaecological Oncologist at the Mater Private Network in Dublin. Together, they will dive into how HIPEC is transforming outcomes for patients with ovarian cancer, offering hope in even the most challenging cases.
Download podcastToday, in our episode before Christmas, I get the discuss the current challenges in cervical screening with Dr Tracie Miles (The Eve Appeal) and Dr Jen Davies (University of Manchester).
We talk all manner of things, from barriers to uptake both in the UK and in resource poor settings to urine based/non-invasive screening methods. We also highlight the best ways to communicate to patients in colposcopy and the areas of communication we often get wrong. Enjoy
Download podastWelcome to this special episode of the BGCS podcast, where we’re spotlighting one of the biggest events in the gynaecological cancer calendar – the British Gynaecological Cancer Society Annual Scientific Meeting 2025, taking place in just two weeks in the heart of London. We’re thrilled to be joined by two exceptional guests. First, Professor Ronny Drapkin, internationally renowned for his pioneering work identifying the fallopian tube as the origin of many high-grade serous ovarian cancers – a discovery that has fundamentally reshaped our understanding of this disease. And second, Professor Ranjit Manchanda, Chair of BGCS ASM 2025, who gives us a preview of what to expect at this year’s meeting – from cutting-edge science and surgical innovation, to global collaboration and the latest in prevention and early detection. Whether you’re a clinician, researcher, nurse specialist or trainee, this episode will get you excited for the science, the networking, and the vision driving progress in gynaecological oncology. Let’s dive in.
Download PodcastMenopause care after cancer and in those at high risk of cancer
In this episode of the BGCS podcast, I am joined by Dr Kristyn Manley from the University Hospitals Bristol Menopause Service, and Georgina Hoffmann, who lives with Lynch syndrome. Together, we focus on the challenges and consequences of surgical menopause for women who have had gynaecological cancer or who undergo risk-reducing surgery because of an inherited cancer predisposition. The conversation explores the profound physical and psychological impact of abrupt menopause following bilateral oophorectomy, often at a young age. We discuss how surgical menopause differs from natural menopause, with more sudden and severe symptoms including vasomotor symptoms, sexual dysfunction, sleep disturbance, cognitive change, and long-term risks to bone and cardiovascular health. Dr Manley provides expert insight into the management of surgical menopause in women with cancer or increased cancer risk, addressing common misconceptions around hormone replacement therapy. She outlines when HRT can be safely offered, how decisions should be individualised based on cancer type and risk profile, and the importance of not denying symptom relief by default. Non-hormonal strategies and supportive interventions are also discussed, particularly for women in whom HRT is contraindicated or declined. Georgina Hoffmann shares her lived experience of surgical menopause in the context of Lynch syndrome, highlighting the real-world impact of risk-reducing surgery on quality of life, identity, and wellbeing. Her contribution reinforces the importance of early counselling, realistic expectations, and ongoing specialist follow-up rather than viewing surgery as the end of the care pathway. The episode emphasises the need for closer integration between gynaecological oncology, genetics, and menopause services, and calls for proactive, compassionate, and evidence-based care for women experiencing surgical menopause. It makes a strong case for recognising menopause management as a core component of cancer survivorship and inherited cancer risk care, rather than an optional add-on.